Xiaowei Xu
Vice Chair for Translational and Clinical Research · University of Pennsylvania Health System
Credentials: · · · · ·
History
- 1999–2001
- 1999–2001
1996–1997- 1996–1997
- 1995–1996
Preliminary or Transitional Year
- 1992–1993
Research
Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response
Nature · 2018 · 2,334 citations
Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
Nature · 2015 · 2,020 citations
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
Nature · 2010 · 1,436 citations
80 papers · 1 as a fellow
67 papers
61 papers
53 papers
44 papers
27 papers · 22 as a fellow
25 papers
24 papers
Grants
- 2024–2028
Designer Extracellular Vesicles for Cancer Therapy
National Cancer Institute · R01
Contact PI · $1.9M · University of Pennsylvania
- 2021–2026
- 2021–2026
Gamma Delta T Cell Based Melanoma Therapies
National Cancer Institute · R01
Contact PI · $3.3M · University of Pennsylvania
- 2008–2025
Targeted Therapies in Melanoma
National Cancer Institute · P01
Project lead · $1.8M · Wistar Institute